This Project Grant award from the U.S. Department of Health and Human Services' Health Resources and Services Administration (HRSA), under the Community Health Centers (CFDA 93.224) federal grant program, provides $600,000 to Promise Healthcare, a Federally Qualified Health Center located in Champaign, Illinois, to expand and enhance behavioral health and substance use disorder treatment services. The key products and services funded under this two-year grant include: hiring a full-time...
The Substance Abuse and Mental Health Services Administration (SAMHSA) has awarded a $55,500,000 Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) grant to the American Academy of Addiction Psychiatry (AAAP). This 4-year project grant, titled "Opioid Response Network: Collaborating, Advancing, Responding, Educating (CARE TEAM)," aims to provide training and technical assistance (TTA) across all 50 states and 9 territories to address...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $1,116,804 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to Cope Community Services, Inc., a non-profit organization in Tucson, Arizona. The 5-year grant, awarded on September 30, 2024, will fund the NEXUS program, which aims to expand prevention and treatment services for substance use disorder, co-occurring mental health...
This $600,000 Project Grant awarded by the U.S. Department of Health and Human Services' Health Resources and Services Administration under the Community Health Centers (CFDA 93.224) program is intended to significantly expand access to medication-assisted treatment (MOUD) and substance use disorder/opioid use disorder (SUD/OUD) treatment, as well as mental health counseling, for the unsheltered population and youth/young adults in Western Sonoma County, California. Key products and services...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Abuse and Addiction Research Programs (CFDA 93.279) provides $318,257 to Cari Health, Inc. to develop a therapeutic monitoring system (TMS) for remote medication compliance tracking of methadone treatment for opioid use disorder (OUD). The key products and services to be delivered include: 1) Integrating an electrochemical sensor, microneedle array, and data pipeline into a prototype wearable...
This Cooperative Agreement award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and commercialize a new technology-enabled approach for more personalized methadone dosing for the treatment of opioid use disorder (OUD). The $2,402,305 award, spanning July 2024 to June 2027, will fund the development and validation of a point-of-care device that can quickly assess an individual patient's methadone metabolism...
The Health Resources and Services Administration (HRSA) awarded Erie Family Health Center, Inc., a Federally Qualified Health Center in Chicago, Illinois, a $1,100,000 federal Project Grant under the Community Health Centers (CFDA 93.224) program. The grant will fund a two-year effort to expand the organization's behavioral health services, including substance use disorder treatment and medication-assisted treatment for opioid use disorders. Key activities include increasing staffing with a...
This $600,000 Project Grant awarded by the Health Resources and Services Administration (HRSA) under the Community Health Centers (CFDA 93.224) program aims to expand behavioral health services and treatment for adolescents and young adults with substance use disorders in Oakland, California. The key goals of the grant are to: 1) Hire additional licensed clinical social workers to provide mental health care within the medical home setting, 2) Develop a curriculum and expand education for primary...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $385,000.00 to Loyola University of Chicago's Health Sciences Campus to conduct a comprehensive analysis of integrated treatment approaches for patients with co-occurring opioid use disorder (OUD) and alcohol use disorder (AUD). The research aims to assess the effectiveness of integrated treatment regimens, including first-line OUD and AUD...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $942,000 Project Grant under the Congressional Directives program (CFDA 93.493) to Clark County, Nevada to implement a Medication-Assisted Treatment (MAT) program for the incarcerated population with opioid use disorder (OUD). The 12-month program, set to run from September 2024 to September 2025, will provide screening, assessment, behavioral health counseling, and access to FDA-approved medications to treat OUD...